Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash#United_States#Azitra#Branford#ATR-04#EGFR_inhibitors
Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash
Azitra, Inc. has advanced to Cohort 2 in its ATR-04 Phase 1/2 clinical trial, addressing skin rashes caused by cancer treatments with positive safety data.
third-news.com
October 1, 2026 at 12:14 PM
Azitra, Inc. Progresses to Phase 2 in Clinical Trial for EGFRi-Associated Skin Rash#United_States#Azitra#Branford#ATR-04#EGFR_inhibitors
#AZTR Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
October 1, 2026 at 12:00 PM
#AZTR Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-advances-atr-04-phase-1-2-clinical-trial-to-cohort-2-fgylmlrr7u9v.html?utm_source=stocktitan-bluesky&utm_medium=social
🚀 Zacks Small Cap Research - AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
September 29, 2026 at 5:45 AM
🚀 Zacks Small Cap Research - AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash Programs
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-aztr-updated-valuation-reflects-cosmetic-and-egfri-rash-programs/
#AZTR #Azi#AZTRB#Azitra##Biotecht#BiotechStocks#Cos/hashtag/Cosmetics" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Cosmetics
Azitra prices $1.5mm private placement @ $0.32
*Includes 5 year warrant exercisable @ $0.32
$AZTR
finance.yahoo.com/news/azitra-...
*Includes 5 year warrant exercisable @ $0.32
$AZTR
finance.yahoo.com/news/azitra-...
Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules
Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has entered into...
finance.yahoo.com
November 26, 2025 at 3:11 PM
Azitra prices $1.5mm private placement @ $0.32
*Includes 5 year warrant exercisable @ $0.32
$AZTR
finance.yahoo.com/news/azitra-...
*Includes 5 year warrant exercisable @ $0.32
$AZTR
finance.yahoo.com/news/azitra-...
Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations#USA#Azitra#ATR-12#Branford#NYSE_American
Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations
Azitra, Inc. has received a non-compliance notification from NYSE American concerning their financial standings. This notice could impact their continued operations and listings.
third-news.com
March 13, 2026 at 9:24 PM
Azitra Faces NYSE American Non-Compliance Notice: Implications for Future Operations#USA#Azitra#ATR-12#Branford#NYSE_American
Aagh! I’m going to be DMing for the first time in awhile, and I finally got my map of Azitra done. Azitra is a technologically advanced archipelago in Eirdane. Very isolated, very steampunk/1800s while the rest of the world is in medieval times. I’ll be uploading the individual countries soon #D&D
October 8, 2023 at 12:57 AM
Aagh! I’m going to be DMing for the first time in awhile, and I finally got my map of Azitra done. Azitra is a technologically advanced archipelago in Eirdane. Very isolated, very steampunk/1800s while the rest of the world is in medieval times. I’ll be uploading the individual countries soon #D&D
Azitra raises $10.5mm via private placement
*Will support new program in cosmetics
*Opportunity discussed in our report s27.q4cdn.com/906368049/fi...
#$AZTR
ir.azitrainc.com/news-release...
*Will support new program in cosmetics
*Opportunity discussed in our report s27.q4cdn.com/906368049/fi...
#$AZTR
ir.azitrainc.com/news-release...
Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million | Azitra, Inc.
Initial funding of approximately $10.5MM in convertible preferred stock and up to an additional $20.9MM upon cash exercise of warrants Financing marks launch of Azitra new innovative protein and pepti...
ir.azitrainc.com
March 19, 2026 at 8:50 PM
Azitra raises $10.5mm via private placement
*Will support new program in cosmetics
*Opportunity discussed in our report s27.q4cdn.com/906368049/fi...
#$AZTR
ir.azitrainc.com/news-release...
*Will support new program in cosmetics
*Opportunity discussed in our report s27.q4cdn.com/906368049/fi...
#$AZTR
ir.azitrainc.com/news-release...
🚨 $AZTR
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
SEC Filing: AZTR
Click to view the official SEC document.
www.sec.gov
September 28, 2026 at 8:50 PM
🚨 $AZTR
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
On September 28, 2026, Azitra, Inc. entered into a sales agreement with A.G.P./Alliance Global Partners , pursuant to which the Company may issue and sell, from time to time, to or through A.G.P., in the Company’s sole discretion, shares of its common stock, par value $0.0001 per share , ...
Azitra gives its poster presentation today @ ASGCT in Boston.
COO Travis Whitfill invites you to stop by the Menino Convention Center.
An Engineered Human Filaggrin Secreting Staphylococcus epidermidis Strain for the Topical Treatment of Ichthyosis Vulgaris
#$AZTR
ir.azitrainc.com/news-release...
COO Travis Whitfill invites you to stop by the Menino Convention Center.
An Engineered Human Filaggrin Secreting Staphylococcus epidermidis Strain for the Topical Treatment of Ichthyosis Vulgaris
#$AZTR
ir.azitrainc.com/news-release...
Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris | Azitra, Inc.
Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity and supporting advancement toward first-in-human studies BRANFORD, Conn., April 28, 2026 /PRNewswire...
ir.azitrainc.com
May 12, 2026 at 1:36 PM
Azitra gives its poster presentation today @ ASGCT in Boston.
COO Travis Whitfill invites you to stop by the Menino Convention Center.
An Engineered Human Filaggrin Secreting Staphylococcus epidermidis Strain for the Topical Treatment of Ichthyosis Vulgaris
#$AZTR
ir.azitrainc.com/news-release...
COO Travis Whitfill invites you to stop by the Menino Convention Center.
An Engineered Human Filaggrin Secreting Staphylococcus epidermidis Strain for the Topical Treatment of Ichthyosis Vulgaris
#$AZTR
ir.azitrainc.com/news-release...
#AZTR Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-full-year-2025-results-and-provides-business-lsojsosdqs86.html
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-full-year-2025-results-and-provides-business-lsojsosdqs86.html
Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates
Azitra (NYSE American: AZTR) reported full-year 2025 results and clinical progress. Key clinical advances include dosing the first patient in the Phase 1/2 ATR-04 trial (EGFRi-associated rash), Fast Track designation for ATR-04, promising Phase 1b safety data for ATR-12 in Netherton syndrome, and positive preclinical ATR-01 data.Financials: R&D $4.8M, G&A $6.2M, net loss $11.0M, and cash & equivalents $2.1M; completed $8.5M financing activity in 2025.
www.stocktitan.net
February 27, 2026 at 10:30 PM
#AZTR Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-full-year-2025-results-and-provides-business-lsojsosdqs86.html
https://www.stocktitan.net/news/AZTR/azitra-inc-announces-full-year-2025-results-and-provides-business-lsojsosdqs86.html
Speaking of Indian places have you been to Azitra and is the wine selection there really as spectacular as it looks online?
December 21, 2024 at 3:30 AM
Speaking of Indian places have you been to Azitra and is the wine selection there really as spectacular as it looks online?
#AZTR Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
https://www.stocktitan.net/news/AZTR/azitra-inc-ceo-issues-letter-to-shareholders-detailing-strategic-tul2oqx557eh.html
https://www.stocktitan.net/news/AZTR/azitra-inc-ceo-issues-letter-to-shareholders-detailing-strategic-tul2oqx557eh.html
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
Azitra (NYSE American: AZTR) CEO outlined a strategic reorientation toward programs with nearer-term value milestones, backed by a March 2026 financing of $10.5 million plus up to $21 million from warrant exercises.Key moves include launching the ATR-COSF cosmetic filaggrin initiative, new recombinant protein programs, continued ATR-04 enrollment, and pausing ATR-12 enrollment to conserve capital, with multiple potential partnering or commercialization opportunities from 2026 onward.
www.stocktitan.net
June 17, 2026 at 12:00 PM
#AZTR Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
https://www.stocktitan.net/news/AZTR/azitra-inc-ceo-issues-letter-to-shareholders-detailing-strategic-tul2oqx557eh.html
https://www.stocktitan.net/news/AZTR/azitra-inc-ceo-issues-letter-to-shareholders-detailing-strategic-tul2oqx557eh.html
We speak with Azitra’s COO Travis Whitfill about EGFRi associated rash and the rationale behind ATR-04.
$AZTR
#Azitra #NethertonSyndrome #RareDisease
$AZTR
#Azitra #NethertonSyndrome #RareDisease
August 21, 2025 at 2:24 PM
We speak with Azitra’s COO Travis Whitfill about EGFRi associated rash and the rationale behind ATR-04.
$AZTR
#Azitra #NethertonSyndrome #RareDisease
$AZTR
#Azitra #NethertonSyndrome #RareDisease
The piece I finished. Only took me about 20~ish hours. The actual attack is so minimal compared to this. 😹
August 13, 2026 at 8:56 AM
The piece I finished. Only took me about 20~ish hours. The actual attack is so minimal compared to this. 😹
#Trading #Stocks
Stock Premarket - Aug 22, 2025
See StockQuakes.substack.com
UP
↑ EEIQ Epicquest Education Group ... 156.1%
↑ LIMN Liminatus Pharma, Inc. 36.7%
↑ ELAB Pmgc Holdings Inc. 34.1%
↑ AZTR Azitra, Inc. 31.6%
↑ EDUC Educational Development 20.5%
↑ ANTE Airnet Technology Inc. 15.0%
Stock Premarket - Aug 22, 2025
See StockQuakes.substack.com
UP
↑ EEIQ Epicquest Education Group ... 156.1%
↑ LIMN Liminatus Pharma, Inc. 36.7%
↑ ELAB Pmgc Holdings Inc. 34.1%
↑ AZTR Azitra, Inc. 31.6%
↑ EDUC Educational Development 20.5%
↑ ANTE Airnet Technology Inc. 15.0%
StockQuakes | StockQuakes Team | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.
StockQuakes.substack.com
August 22, 2025 at 12:39 PM
#Trading #Stocks
Stock Premarket - Aug 22, 2025
See StockQuakes.substack.com
UP
↑ EEIQ Epicquest Education Group ... 156.1%
↑ LIMN Liminatus Pharma, Inc. 36.7%
↑ ELAB Pmgc Holdings Inc. 34.1%
↑ AZTR Azitra, Inc. 31.6%
↑ EDUC Educational Development 20.5%
↑ ANTE Airnet Technology Inc. 15.0%
Stock Premarket - Aug 22, 2025
See StockQuakes.substack.com
UP
↑ EEIQ Epicquest Education Group ... 156.1%
↑ LIMN Liminatus Pharma, Inc. 36.7%
↑ ELAB Pmgc Holdings Inc. 34.1%
↑ AZTR Azitra, Inc. 31.6%
↑ EDUC Educational Development 20.5%
↑ ANTE Airnet Technology Inc. 15.0%
Azitra adds new site @ MD Anderson for its Ph1/2 ATR04 trial.
Trial will evaluate ATR04 in EGFRi-associated skin rash. Now enrolling a target of 8 patients in Cohort 1.
#$AZTR
ir.azitrainc.com/news-release...
Trial will evaluate ATR04 in EGFRi-associated skin rash. Now enrolling a target of 8 patients in Cohort 1.
#$AZTR
ir.azitrainc.com/news-release...
ir.azitrainc.com
February 24, 2026 at 1:48 PM
Azitra adds new site @ MD Anderson for its Ph1/2 ATR04 trial.
Trial will evaluate ATR04 in EGFRi-associated skin rash. Now enrolling a target of 8 patients in Cohort 1.
#$AZTR
ir.azitrainc.com/news-release...
Trial will evaluate ATR04 in EGFRi-associated skin rash. Now enrolling a target of 8 patients in Cohort 1.
#$AZTR
ir.azitrainc.com/news-release...
🚨 PRE-MARKET MOVERS — Mar 20, 2026
🟢 GAINERS 🟢
🧬 #$AZTR +88% | Azitra Inc.
Micro-cap biotech SQUEEZING hard 🔥
$31.4M private placement SECURED
Stonepine Capital + Nantahala + CEO buying IN
Was facing delisting... now it has runway 💉
Mkt Cap: $2.85M — this is a knife 🔪 DYOR
🛰️ #$PL +19% | Planet Labs
🟢 GAINERS 🟢
🧬 #$AZTR +88% | Azitra Inc.
Micro-cap biotech SQUEEZING hard 🔥
$31.4M private placement SECURED
Stonepine Capital + Nantahala + CEO buying IN
Was facing delisting... now it has runway 💉
Mkt Cap: $2.85M — this is a knife 🔪 DYOR
🛰️ #$PL +19% | Planet Labs
March 20, 2026 at 12:26 PM
Black woman joy! Look at her Lego collection! This makes me so happy 🥰
Replying to @Azitra👅🖕 You guys asked so you shall receive. thank you for all of the love you guys have been showing my mom she truly is one of one ❤️ Follow her @@MamaThel❌ @@LEGO ##fyp##legos##tikto...
TikTok video by Ebony Williams
www.tiktok.com
December 28, 2025 at 8:19 AM
Black woman joy! Look at her Lego collection! This makes me so happy 🥰
#Trading #Stock #AI
Stock Premarket - Oct 20, 2025
See StockQuakes.substack.com
UP
↑ REPL Replimune Group, Inc. 91.3%
↑ AZTR Azitra, Inc. 82.0%
↑ BYND Beyond Meat 59.5%
↑ CELC Celcuity 50.3%
DOWN
↓ OLMA Olema Pharma -31.9%
↓ SLGB Smart Logistics Global -19.7%
↓ GMAB Genmab AS -5.0%
Stock Premarket - Oct 20, 2025
See StockQuakes.substack.com
UP
↑ REPL Replimune Group, Inc. 91.3%
↑ AZTR Azitra, Inc. 82.0%
↑ BYND Beyond Meat 59.5%
↑ CELC Celcuity 50.3%
DOWN
↓ OLMA Olema Pharma -31.9%
↓ SLGB Smart Logistics Global -19.7%
↓ GMAB Genmab AS -5.0%
StockQuakes | StockQuakes Team | Substack
Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.
StockQuakes.substack.com
October 20, 2025 at 12:36 PM
#Trading #Stock #AI
Stock Premarket - Oct 20, 2025
See StockQuakes.substack.com
UP
↑ REPL Replimune Group, Inc. 91.3%
↑ AZTR Azitra, Inc. 82.0%
↑ BYND Beyond Meat 59.5%
↑ CELC Celcuity 50.3%
DOWN
↓ OLMA Olema Pharma -31.9%
↓ SLGB Smart Logistics Global -19.7%
↓ GMAB Genmab AS -5.0%
Stock Premarket - Oct 20, 2025
See StockQuakes.substack.com
UP
↑ REPL Replimune Group, Inc. 91.3%
↑ AZTR Azitra, Inc. 82.0%
↑ BYND Beyond Meat 59.5%
↑ CELC Celcuity 50.3%
DOWN
↓ OLMA Olema Pharma -31.9%
↓ SLGB Smart Logistics Global -19.7%
↓ GMAB Genmab AS -5.0%
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference#United_States#New_York#biotechnology#Azitra#ATR-COSF
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference
Azitra, Inc. will participate in the H.C. Wainwright Annual Conference, where it will present key developments in its biopharmaceutical pipeline and innovative research.
third-news.com
September 8, 2026 at 12:16 PM
Azitra, Inc. to Showcase Advances at H.C. Wainwright Annual Conference#United_States#New_York#biotechnology#Azitra#ATR-COSF
#AZTR Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 8, 2026 at 12:00 PM
#AZTR Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-at-the-h-c-wainwright-28th-annual-global-rffqkfbx6tqh.html?utm_source=stocktitan-bluesky&utm_medium=social